ARYA SCIENCES ACQUISITION CORP.

ARYA Sciences Acquisition Corp., trading under the ticker ARYA, is a blank-check company that completed its initial public offering in 2019 with a focus on the life sciences and biopharmaceutical sector. The SPAC is sponsored by ARYA Sciences Holdings LLC, an affiliate of Perceptive Advisors, a healthcare-focused investment firm with an established track record in the biopharma space. The 10-Q filing dated November 13, 2019, with accession number 0001193125-19-291106, reflects the company's financial position during its search for a qualifying business combination target. ARYA Sciences Acquisition Corp. represents one of several life sciences-oriented vehicles Perceptive Advisors has brought to public markets. Sign up for SpacDesk to access the full filing history, key dates, and deal metrics for ARYA and hundreds of other SPACs.